These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 25703958)

  • 1. Involving patients in health technology funding decisions: stakeholder perspectives on processes used in Australia.
    Lopes E; Street J; Carter D; Merlin T
    Health Expect; 2016 Apr; 19(2):331-44. PubMed ID: 25703958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Power relations and contrasting conceptions of evidence in patient-involvement processes used to inform health funding decisions in Australia.
    Lopes E; Carter D; Street J
    Soc Sci Med; 2015 Jun; 135():84-91. PubMed ID: 25950114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community views and perspectives on public engagement in health technology assessment decision making.
    Wortley S; Tong A; Howard K
    Aust Health Rev; 2017 Mar; 41(1):68-74. PubMed ID: 27050156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAKEHOLDER INVOLVEMENT IN THE HEALTH TECHNOLOGY ASSESSMENT PROCESS IN LATIN AMERICA.
    Pichon-Riviere A; Soto N; Augustovski F; Sampietro-Colom L
    Int J Technol Assess Health Care; 2018 Jan; 34(3):248-253. PubMed ID: 29888698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health technology assessment in Australia: a role for clinical registries?
    Scott AM
    Aust Health Rev; 2017 Mar; 41(1):19-25. PubMed ID: 27028134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FRAMEWORK FOR USER INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT AT THE LOCAL LEVEL: VIEWS OF HEALTH MANAGERS, USER REPRESENTATIVES, AND CLINICIANS.
    Gagnon MP; Desmartis M; Gagnon J; St-Pierre M; Rhainds M; Coulombe M; Tantchou MD; Légaré F
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):68-77. PubMed ID: 25952585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAKEHOLDER INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT AT NATIONAL LEVEL: A STUDY FROM IRAN.
    Yazdizadeh B; Shahmoradi S; Majdzadeh R; Doaee S; Bazyar M; Souresrafil A; Olyaeemanesh A
    Int J Technol Assess Health Care; 2016 Jan; 32(3):181-9. PubMed ID: 27524462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision making in NICE single technological appraisals: How does NICE incorporate patient perspectives?
    Hashem F; Calnan MW; Brown PR
    Health Expect; 2018 Feb; 21(1):128-137. PubMed ID: 28686809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA.
    Janssens R; Russo S; van Overbeeke E; Whichello C; Harding S; Kübler J; Juhaeri J; Bywall KS; Comanescu A; Hueber A; Englbrecht M; Nikolenko N; Pravettoni G; Simoens S; Stevens H; Hermann R; Levitan B; Cleemput I; de Bekker-Grob E; Veldwijk J; Huys I
    Patient; 2019 Oct; 12(5):513-526. PubMed ID: 31222436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability and Perceived Benefits and Risks of Public and Patient Involvement in Health Care Policy: A Delphi Survey in Belgian Stakeholders.
    Cleemput I; Christiaens W; Kohn L; Léonard C; Daue F; Denis A
    Value Health; 2015 Jun; 18(4):477-83. PubMed ID: 26091602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stakeholder involvement in expensive drug recommendation decisions: an international perspective.
    Rosenberg-Yunger ZR; Thorsteinsdóttir H; Daar AS; Martin DK
    Health Policy; 2012 May; 105(2-3):226-35. PubMed ID: 22226141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rationale and design of public involvement in health-funding decision making: focus groups with the Canadian public.
    Lopes E; Street J; Stafinski T; Merlin T; Carter D
    Int J Technol Assess Health Care; 2020 Dec; 36(6):592-598. PubMed ID: 32753071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social values and health priority setting in Australia: an analysis applied to the context of health technology assessment.
    Whitty JA; Littlejohns P
    Health Policy; 2015 Feb; 119(2):127-36. PubMed ID: 25267072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferences for engagement in health technology assessment decision-making: a nominal group technique with members of the public.
    Wortley S; Tong A; Howard K
    BMJ Open; 2016 Feb; 6(2):e010265. PubMed ID: 26832433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of stakeholder involvement in hospital policy decision-making: a study of the hospital's business processes.
    Malfait S; Van Hecke A; Hellings J; De Bodt G; Eeckloo K
    Acta Clin Belg; 2017 Feb; 72(1):63-71. PubMed ID: 27762170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sector cooperation in health-enhancing physical activity policymaking: more potential than achievements?
    Hämäläinen RM; Aro AR; Lau CJ; Rus D; Cori L; Syed AM;
    Health Res Policy Syst; 2016 Apr; 14(1):33. PubMed ID: 27129850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysis.
    Kaltenthaler E; Carroll C; Hill-McManus D; Scope A; Holmes M; Rice S; Rose M; Tappenden P; Woolacott N
    Health Technol Assess; 2016 Apr; 20(26):1-48. PubMed ID: 27049841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involving stakeholders and developing a policy for stakeholder involvement in the European network for health technology assessment, EUnetHTA.
    Nielsen CP; Lauritsen SW; Kristensen FB; Bistrup ML; Cecchetti A; Turk E;
    Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():84-91. PubMed ID: 20030895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.